🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Chronic Liver Disease and ACLF

Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry NCT07480057n/a1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: no intervention Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure (ACLF) Patients With Severe Coagulopathy NCT06831565NA1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: ROTEM ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF NCT07329036NA1 site📍 Prague Institute for Clinical and Experimental Medicine · Tests: The artificial liver support system (ALSS) - DPMAS/TPE A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device. NCT07347275NA1 site📍 London Yaqrit Ltd · Tests: Standard of Care (Investigator Choice), DIALIVE 2.0 liver dialysis Device plus available Standard of Care Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients NCT06916585Phase 21 site📍 Shenzhen Shenzhen Third People's Hospital · Tests: AS1501 for injection Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs NCT04613921n/a106 sites📍 Los Angeles📍 Aurora📍 Tampa European Foundation for Study of Chronic Liver Failure · Tests: Observational Protocol Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis NCT06562803NA1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: double plasma cytokine adsorption system with sequential low-dose plasma exchange, plasma exchange Study About Hepatic Toxins Kinetic and Evaluation of Organ Damage in Acute on Chronic Liver Failure (ACLF) Patients NCT06837766n/a3 sites📍 Ancona📍 Bologna📍 Milan IRCCS Azienda Ospedaliero-Universitaria di Bologna A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial). NCT05895136Phase 29 sites📍 Clichy📍 Aachen📍 Münster European Foundation for Study of Chronic Liver Failure · Tests: Human albumin, Enoxaparin, Standard medical treatment Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study NCT06948565n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon · Tests: observational study Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease NCT04578301n/a1 site📍 Bonn University Hospital, Bonn · Tests: No Intervention A-TANGO Phase 2 Study NCT06890039Phase 21 site📍 London Yaqrit Ltd · Tests: Placebo, TAK-242, G-CSF (Filgrastim) Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF NCT04597164n/a1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: Artificial liver support system
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy